Pelikan closes $25M for handheld diagnostics
Pelikan Technologies, maker of medical devices for diagnosing and monitoring diabetes, just brought in $25 million from undiclosed investors, reports VentureWire. Based in Palo Alto, Calif., the company spun out of Agilent Technologies in 2001 with the launch of its Pelikan Sun line, an electronic lancing device used to test blood sugar.
This round of capital brings its total raised to $145 million (it last raised $89 million at the end of 2007). Past investors (that… Continue Reading
Pelikan scoops up $12.5M for diabetes diagnostics
Pelikan Technologies, maker of diagnostic and health-monitoring devices that can be used by regular people, nabbed a $12.5 million tranche of an expected $25 million seventh round of funding, according to VentureWire. Its flagship product, the handheld diabetes tester Pelikan Sun, is already on the market and is even being targeted for children.
The Palo Alto, Calif.-based company has raised $145 million to date. Its most recent round amounted to $69 million last December. Contributors to… Continue Reading
Pelikan Tech to push “finger friendly” diabetes testing
One of the constant but unavoidable challenges in trying to control diabetes is the frequent need to test blood-sugar levels by sticking a needle into a fingertip — a step that tells diabetics when they need a snack (to raise blood glucose) or a shot of insulin (to lower it). “Lancing” fingers several times a day can render the tips so tender that it restricts ordinary activity — playing the piano, for instance — for… Continue Reading